Health Professional Radio - Podcast

Dr. Barbara White, Chief Medical Officer at Corbus Pharmaceuticals discusses Lenabasum, Corbus' lead drug candidate that activates the often underutilized endocannabinoid system (ECS) to treat systemic sclerosis. Its Phase III trial recently completed treatment and is projected to release its data by the end of summer 2020.